Literature DB >> 1869431

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival.

J S Sham1, D Choy.   

Abstract

The local tumor control of 262 patients with nasopharyngeal carcinoma (NPC) at median follow-up of 27 months was studied with reference to the paranasopharyngeal and other aspects of extranasopharyngeal extension of tumor, as well as to other possible prognostic factors. Only cranial nerve palsy, oropharyngeal involvement, and paranasopharyngeal extension of tumor were found to be significant in a multivariate analysis using Cox model for factors influencing local tumor control. Other factors and other parameters of extranasopharyngeal extension of tumor, namely, erosion of the base of skull, intracranial extension, and involvement of nasal fossa, were found not be significant. The degree of paranasopharyngeal extension in each side was correlated with scales measuring extranasopharyngeal extension of tumor in other directions (p = 0.001). Although the T stage and the paranasopharyngeal extension were individually found to be well correlated with local tumor control, the prognostic value of paranasopharyngeal extension remained significant among subgroups of patients with T3 and T4 disease (p = 0.1044 and 0.0010, respectively).

Entities:  

Mesh:

Year:  1991        PMID: 1869431     DOI: 10.1002/hed.2880130406

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Challenges in the management of nasopharyngeal carcinoma: a review.

Authors:  Baharudin Abdullah; Azila Alias; Shahid Hassan
Journal:  Malays J Med Sci       Date:  2009-10

2.  A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.

Authors:  L Kostakoglu; U Uysal; E Ozyar; F B Demirkazik; M Hayran; L Atahan; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1997-06

Review 3.  Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread.

Authors:  Roberto Maroldi; Claudia Ambrosi; Davide Farina
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

4.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

Review 5.  Contribution of radiotherapy to function preservation and cancer outcome in primary treatment of nasopharyngeal carcinoma.

Authors:  Anne W M Lee
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

6.  MR imaging prediction of local control of nasopharyngeal carcinoma treated with radiation therapy and chemotherapy.

Authors:  Y Wang; H Zhao; Z-Q Zhang; L-L Huang; Y Ye; Y-B Wang; M-J Han
Journal:  Br J Radiol       Date:  2014-05-14       Impact factor: 3.039

7.  Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma.

Authors:  Edmond H N Pow; Anne S McMillan; W Keung Leung; May C M Wong; Dora L W Kwong
Journal:  Clin Oral Investig       Date:  2003-08-29       Impact factor: 3.573

8.  Intensity modulated radiotherapy: advantages, limitations and future developments.

Authors:  Ky Cheung
Journal:  Biomed Imaging Interv J       Date:  2006-01-01

9.  Prognostic value of classifying parapharyngeal extension in nasopharyngeal carcinoma based on magnetic resonance imaging.

Authors:  Guo-Yi Zhang; Ying Huang; Xue-Feng Hu; Xiang-Ping Chen; Tao Xu; Li-Zhi Liu; Wei-Hong Wei; Guo-Sen Huang; Miao-Miao Zhou; Ze-Li Huang; Yue-Jian Wang
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

10.  Prognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.

Authors:  Seung Hwan Moon; Joon Young Choi; Hwan Joo Lee; Young-Ik Son; Chung-Hwan Baek; Yong Chan Ahn; Myung-Ju Ahn; Keunchil Park; Byung-Tae Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.